You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 20, 2025

Using High Content Imaging to Quantify Target Engagement in Adherent Cells
Published on: November 29, 2018
Brandon J Ausk1, Adam N Tucker2, Philippe Huber2
1In Situ Therapeutic Solutions Inc, Seattle, USA. brandon.ausk@istherasol.com.
Distributed dosing of botulinum toxin type A (BTxA) significantly improves soft-tissue drug coverage compared to single-bolus injections. This microcomputed tomography (microCT) imaging platform enables precise quantification for optimizing heterotopic ossification prophylaxis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: